Insider · CIK 0001878193
Dale A. Sander
cfoofficer
Files at HUMA (Humacyte, Inc.). First filing Apr 14, 2025, latest Apr 14, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$31k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HUMA: Humacyte, Inc.
HUMAOct 9, 2026 · close 0.41
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Humacyte, Inc. | $31k 20,000 shares | +97% | +37% from low-74% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 10, 2025 | HUMA Humacyte, Inc. | POpen-market purchase Common Stockindirect: By spouse | +20,000 | $1.53 | $31k | 40,600 | Apr 14, 2025 |
| Jan 21, 2025 | HUMA Humacyte, Inc. | AGrant or award Stock Options (right to buy)derivative | +283,101 | $0.00 | $0 | 283,101 | Jan 23, 2025 |
| Dec 19, 2024 | HUMA Humacyte, Inc. | AGrant or award Stock Options (right to buy)derivative | +525 | $0.00 | $0 | 2,625 | Dec 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.